Mosaic ImmunoEngineering Inc. (CPMV)

Mosaic ImmunoEngineering Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020	2020	2018
Cash & Equivalents	0.22	0.23	0.35	0.79	2.3
Short-Term Investments	0	0	0.03	0.75	0
Cash & Cash Equivalents	0.22	0.23	0.38	1.54	2.3
Cash Growth	-2.43%	-40.55%	-75.25%	-33.11%	-27.81%
Receivables	0	0	0.03	0.03	0
Inventory	0	0	0	0.17	0.02
Other Current Assets	0.04	0.04	0.05	0.03	0.01
Total Current Assets	0.26	0.27	0.46	1.76	2.33
Property, Plant & Equipment	0	0	0	0	0
Long-Term Investments	0	0	0.03	0.11	0.2
Other Long-Term Assets	0	0	0	0.05	0.05
Total Long-Term Assets	0	0	0.03	0.16	0.25
Total Assets	0.26	0.27	0.46	1.92	2.58
Accounts Payable	0.13	0.11	0.09	0.01	0.04
Other Current Liabilities	3.78	2.22	0.79	0.22	0.04
Total Current Liabilities	3.92	2.33	0.88	0.23	0.08
Long-Term Debt	1.23	0.74	0	0	0
Other Long-Term Liabilities	0	0	0	0.01	0.04
Total Long-Term Liabilities	1.23	0.74	0	0.01	0.04
Total Liabilities	5.15	3.07	0.88	0.23	0.08
Total Debt	1.23	0.74	0	0	0
Debt Growth	67.09%	-	-	-	-
Common Stock	0	0	0	0	0
Retained Earnings	-6.91	-4.53	-0.84	-61.13	-60.33
Shareholders' Equity	-4.88	-2.8	-0.42	1.7	2.5
Total Liabilities and Equity	0.26	0.27	0.46	1.92	2.58
Net Cash / Debt	-1.01	-0.51	0.38	1.54	2.3
Net Cash / Debt Growth	-	-	-75.25%	-33.11%	-27.81%
Net Cash Per Share	-0.14	-0.08	0.48	1.93	2.88
Working Capital	-3.66	-2.06	-0.42	1.54	2.24
Book Value Per Share	-0.68	-0.42	-0.53	2.13	3.13

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.